We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Events

09 Apr 2024 - 12 Apr 2024
15 Apr 2024 - 17 Apr 2024
23 Apr 2024 - 26 Apr 2024

New Ventless Device Addresses Significant Challenge of Blood Culture Contamination

By LabMedica International staff writers
Posted on 17 Feb 2023
Print article
Image: Kurin Jet marks a significant technological advance over the company’s own market-leading Kurin Lock (Photo courtesy of Kurin)
Image: Kurin Jet marks a significant technological advance over the company’s own market-leading Kurin Lock (Photo courtesy of Kurin)

Determining whether a bloodstream infection is present in patients is vital for their wellbeing as well as for the financial health of hospitals. The gold standard for identifying bacteremia is a blood culture test with millions of such tests being conducted annually to inform patient care decisions. However, contaminated blood cultures create a significant problem, as approximately one-third of all positive results are wrong, resulting in unnecessary antibiotics being administered to patients, longer hospital stays and a negative impact on larger community health issues, like antimicrobial resistance and life-threatening C. diff. infections. Now, a new ventless device with its unique design, speed, and ease of use can help hospitals address the significant challenge of blood culture contamination.

Kurin, Inc. (San Diego, CA, USA) has announced the limited commercial release of Kurin Jet, which is a significant technological advance over the company’s own market-leading Kurin Lock. Kurin’s revolutionary approach to the problem of contaminated blood culture is based on simple, intuitive designs that does not require any additional user steps. Similar to the Kurin Lock, the Kurin Jet also passively sidelines potential contaminants during blood culture collection. Both Kurin Lock and Kurin Jet offer a better and more sustainable approach than active, conventional mechanical diversion.

“We are excited to announce the introduction of Kurin Jet, a fundamentally different product that provides a new level of performance in addressing the blood culture contamination market,” said Bob Rogers, CEO of Kurin, Inc. “Although our current Kurin Lock is the market leader because of its small size and passive, user-friendly design, we have leapfrogged that technology and created a much faster device with a greater level of control for clinicians. Kurin Jet can be used with direct to media, syringe draw, direct venipuncture and PIV applications.”

“Kurin Jet helps hospitals address the significant challenge of blood culture contamination with its unique design, speed, and ease of use. Based on its performance and feedback from those who have used Jet, we will limit the initial release, as demand will exceed initial production volumes. Full release will occur later this year,” added Rogers.

Related Links:
Kurin, Inc.

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Specimen Collection & Transport
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
Plasma Control
Plasma Control Level 1

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: MOF materials efficiently enrich cfDNA and cfRNA in blood through simple operational process (Photo courtesy of Science China Press)

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

The ability to diagnose diseases early can significantly enhance the effectiveness of clinical treatments and improve survival rates. One promising approach for non-invasive early diagnosis is the use... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.